Medline Inc. Class A Common Stock (MDLN) — Capital Reinvestment Ratio
Medline Inc. Class A Common Stock (MDLN) has a Capital Reinvestment Ratio of 0.23x as of March 2026, meaning it reinvests 0% of its operating cash flow ($412.00 Million) in capital expenditures ($96.00 Million). See MDLN equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medline Inc. Class A Common Stock Capital Reinvestment Ratio (2022–2025)
This chart tracks Medline Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods. Check Medline Inc. Class A Common Stock cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medline Inc. Class A Common Stock (2022–2025)
Year-by-year Capital Reinvestment Ratio for Medline Inc. Class A Common Stock from 2022 to 2025. For live market cap and broader valuation context, see MDLN market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $187.00 Million | $254.00 Million | — |